Hairy cell leukemia–variant treated with 2-Chlorodeoxyadenosine—a report of three cases

Leukemia and Lymphoma

Volumn 25, Issue 42067, 1997, Pages 381-385

  Blasinska Morawiec M ^a   Robak, T ^a   Krykowski, E ^a   Hellmann, A ^b   Urbanska Rys H ^a  

^a Medical University of Lódzóul   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

2 chlorodeoxyadenosine; Hairy cell leukemia variant; therapy

Indexed keywords

ADENOSINE DERIVATIVE; CLADRIBINE;

ADULT; AGED; ARTICLE; CASE REPORT; FATALITY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; SPLENOMEGALY; UPPER RESPIRATORY TRACT INFECTION;

AGED; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CLADRIBINE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; SPLEEN; TREATMENT OUTCOME;

EID: 0030999433     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709114177     Document Type: Article

References (23)

1. Bouroncle B. A., Wiseman B. K., Doon C. A. Leukemic reticuloendotheliosis. Blood. 1958; 13: 609 – 630
2. Catovsky D. Prolymphocytic and hairy-cell leukemias. Leukemia 5th edition, W. Dameshek, F. Gunz. W.B. Saunders Comp. 1990; 639 – 660
3. Cawley J. C., Burns G. F., Hayhoe F. G. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leak. Res. 1980; 4: 547 – 559
4. Catovsky D., O'Brien M., Melo J. V., Vardle J., Brozovic M. Hairy cell leukemia variant. An intermediate disease between hairy cell leukemia and B prolymphocytic leukemia. Semin. Oncol. 1984; 11: 363 – 369
5. Sainati L., Matutes E., Mulligan S., De Oliveira M. P., Rani S., Lampert I. A., Catovsky D. A variant form of hairy cell leukemia resistant to α-Interferon: clinical and phenotypic characteristics of 17 patients. Blood 1990; 76: 157 – 162
6. Diez J. L., Li C.-Y., Banks P. M. Blastic variant of hairy cell leukemia. Am. J. Clin. Pathol. 1987; 87: 576 – 583
7. Hanson C. A., Ward P. C., Schnitzer B. A multi-lobular variant of hairy cell leukemia with morphologic similarities to T-cell lymphoma. Am. J. Surg. Pathol. 1989; 13: 671 – 679
8. Invernizzi R., Castello A. A hairy cell leukemia variant with unusual nuclear morphology. Haematologica. 1994; 79: 567 – 568
9. Sun T., Susin M., Shevde N., Teichberg S. Hybrid form of hairy cell leukemia and chronic lymphocytic leukemia. Hentatol. Oncol. 1990; 8: 283 – 294
10. Jansen J., Hermans J. For the collaborative study group. Splenectomy in hairy cell leukemia. A retrospective multicenter analysis. Cancer 1981; 47: 2066
11. Golomb H. M., Fefer A., Golde D. W. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon alfa 2 B. Semin. Oncol. 1988; 15: 7 – 9
12. Quesada J. R., Reuben J., Mauning J. T., Hersh E. M., Gutterman J. U. Alpha interferon for induction of remission in hairy cell leukemia. N. Engl., J. Med. 1984; 310: 15 – 18
13. Spiers A. S., Moore D., Cassileth P. A., Harrington D. P., Cummings F. J., Neiman R. S., Bennett J. M., O'Connel M. J. Remissions in hairy cell leukemia with pentostatin (2′-deoxycoformycin). N. Engl. J. Med. 1987; 316: 825 – 830
14. Saven A., Piro L. D. The newer purine analogues for the treatment of hairy cell leukemia. New Engl. J. Med. 1994; 330: 691 – 697
15. Piro L. D., Carrera C. J., Carson D. L., Beutler E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 1990; 322: 1117 – 1121
16. Robak T., Blasińska-Morawiec M., Krykowski E. 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk. Lymph. 1996; 22 (112) 107 – 112
17. Shibata A., Bennett J. M., Castoldi G. L., Catovsky D., Flandrin G., Jaffe E. S., Kayayama L, Nanba K., Schmalzl F., Yam L. T. Recommended methods for cytological procedures in haematology. Clin. Lab. Haematol. 1985; 7: 55
18. Cordell J. J., Falini B., Erber W. N., Ghosh A. K., Abdullazis L., MacDonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labeling of mono-clonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 52: 219 – 231
19. Kazimierczuk Z., Vilpo J., Hildebrand C., Wright G. Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6-disubstituted purines. J. Med. Chem. 1990; 33: 1683 – 187
20. Melo J. V., Hegde U., Parreira A. Splenic B-cell lymphoma with circulating “villous” lymphocytes: differential diagnosis of B-cell leukaemias with a large spleen. J. Clin. Pathol. 1987; 40: 642
21. Kokai Y., Ishii Y., Kikuchi K. Characterization of two distinct antigens expressed on either resting or activated B-cell as defined by monoclonal antibodies. Clin. Exp. Immunol. 1986; 64: 382
22. Giardina S. L., Young H. A., Faltynek C. R., Jaffe E. S., Clark J. W., Steis R. G., Urba W. J., Mathieson B. J., Gralnick H., Lawrence J., Overton W. R., Longo D. L. Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha. Blood 1988; 72: 1708 – 1718
23. Gollard R., Lec T. C., Piro L. D., Saven A. The optimal management of hairy cell leukaemia. Drugs 1995; 49: 921 – 931